<DOC>
	<DOCNO>NCT00887367</DOCNO>
	<brief_summary>This study investigate possible effect alcohol combination GSK598809 central nervous system 20 healthy male female volunteer , 18 65 year age . During 4 separate study period subject receive follow treatment combination : Alcohol + GSK598809 , alcohol + placebo drug , placebo infusion + GSK598809 , placebo infusion + placebo drug . A placebo pill liquid infusion contains drug alcohol ; dummy version . Therefore administered way either study drug ethanol depend placebo . All study drug administer random order doctor participant aware treatment combination . However treatment combination available end study case emergency . GSK598809 administer orally alcohol administer per infusion . The duration infusion 5 hour , approximately 75 gram alcohol infuse , comparable less one bottle wine .</brief_summary>
	<brief_title>EtOH Interaction Study</brief_title>
	<detailed_description>This blind , randomise , placebo-controlled , double-dummy , four-period crossover study investigate psychomotor cognitive effect GSK598809 alone combination ethanol healthy subject . A sufficient number subject , approximately 20 healthy ( 18 65 year ) male female subject enrol . Occasional smoker non-daily smoker may enrol study , permit smoke whilst unit . Subjects screen medical history , physical examination routine laboratory test within three week start study . Within three week Day -1 train session get familiar pharmacodynamic test . There four crossover session . All study occasions/sessions perform way . The duration treatment session 5 study day . Subjects report clinic even Day -1 fast condition remain clinic two overnight stay . A short study introduction give follow admission procedure . Dinner serve collection blood sample laboratory safety test . On morning study day 1 , approximately 08:00hrs two intravenous cannulae ( one cannula blood sample another cannula infusion ethanol/placebo ) insert . Before start infusion light breakfast give . The alcohol infusion start morning , approximately 09:30hr 10:00hr take place five hour , follow three-hour infusion-free washout period . GSK598809 match placebo administer orally 30 minute start alcohol infusion . A standardised lunch give approximately 3.5 hour post dose dinner approximately 9 hour post dose . Subjects discharge completion study assessment AE review Day 2 deem appropriate investigator designee . Study Days : 3 4 outpatient visit collection pharmacokinetic sample AE review . During session , range central nervous system ( CNS ) function test frequently , use validate CNS-battery , CHDR Neurocart . In addition , pharmacokinetic measurement take plasma level GSK598809 GSK685249 ( GSK598809 metabolite ) . Pharmacokinetic measure also take breath alcohol blood alcohol level . There washout period least five day treatment session . The follow visit take place approximately 7 day post final treatment .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Generally healthy . Occasional nondaily smoker . Willing use appropriate contraception method . Weight 50 kg . BMI within range 18 30 kg/m2 . Pregnant breast feed female . Daily smoker . Asthma history asthma . Abuse drug alcohol . Psychiatric illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Substance dependence</keyword>
	<keyword>Alcohol dependence</keyword>
</DOC>